JUST PUBLISHED - A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

Published on Nature Communications
News typology: 
home
Publish date
Published on: 
06/17/2017

The prolyl isomerase PIN1, a critical modifier of multiple signalling pathways, is overexpressed in the majority of cancers and its activity strongly contributes to tumour initiation and progression. Inactivation of PIN1 function conversely curbs tumour growth and cancer stem cell expansion, restores chemosensitivity and blocks metastatic spread, thus providing the rationale for a therapeutic strategy based on PIN1 inhibition. In this article, the discovery of PIN1 inhibitors with antitumoral activity is described.

Article

Last update: 06-17-2017 - 08:58
Share/Save